Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of cardiovascular disease. Evidence exists for a positive correlation between certain probiotic bacteria and vascular function, glucose tolerance and cholesterol levels.
A clinical study has demonstrated the efficacy of the probiotic Bacillus subtilis DE111® in improved endothelial function and support of healthy cholesterol levels.